See ratings and reviews when you sign up for an account.

An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences With Stress Strategies (BLESS) Study

This study is currently Recruiting

April 2011 By Medical University of South Carolina

First Recieved on May 9, 2011

Last Updated on May 10, 2011

Sponsor: Medical University of South Carolina
Collaborators: Pfizer
Information provided by: Medical University of South Carolina
Identifier: NCT01351662


Linking a psychosocial stress intervention with clinical measures of stress in African American lupus patients will assess the utility of this method in reducing perceived stress, and provide the necessary preliminary steps toward future investigations of potential mechanisms.

Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Health Services Research


Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Inclusion Criteria: - 18 years of age or older - African American - Diagnosis of Lupus Exclusion Criteria: - Previous participation in a disease self management program


  • Investigator: Edith M Williams, PhD - Study Director - University of South Carolina
  • Investigator: James C Oates, MD - Principal Investigator - Medical University of South Carolina


  • Medical University of South Carolina

    Charleston, South Carolina 29425 United States

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.